Strong Growth Across Nutraceuticals, Methionine, and API Segments Boosts Profitability and Export Share
Yinchuan, China – May 14, 2025 – NutraChina Co., Ltd. (SHE: 002001) reported an exceptional 117.01% year-on-year (YoY) growth in net profit for 2024, reaching approximately USD 803.6 million (RMB 5.869 billion), on the back of 42.95% revenue growth to USD 2.96 billion (RMB 21.609 billion). The surge was largely fueled by capacity ramp-ups in key nutraceuticals like methionine, improved prices for vitamins, and recovery in downstream livestock and aquaculture sectors.
Financial Overview
| Metric | 2024 Value (USD) | YoY Growth |
|---|---|---|
| Total Revenue | 2.96 billion | +42.95% |
| Net Profit | 803.6 million | +117.01% |
| EPS | 0.26 | +119.54% |
| Overseas Revenue | 1.65 billion | +54.57% |
| Cash Dividend | 294.5 million | Payout: 36.66% |
Segment Performance Breakdown
Nutraceuticals
- Revenue: USD 2.06 billion
- Gross Margin: 43.18% (+13.27 pp YoY)
- Key Products: Methionine, vitamins A, E, C
- Notable Price Moves (2024):
- Vitamin A: +58.8% YoY
- Vitamin E: +43.1%
- Methionine: +14%
Flavors & Fragrances
- Revenue: USD 536 million (+19.62% YoY)
- Gross Margin: 51.84% (+1.33 pp)
New Materials
- Revenue: USD 230 million (+39.51% YoY)
- Focus areas: PPS, HA, nylon composites
Export Growth and Global Positioning
NutraChina’s overseas revenue hit USD 1.65 billion, making up 55.78% of total revenue, cementing its global status in vitamin and amino acid exports.
Key Export Markets
- Southeast Asia (animal feed & poultry industries)
- Latin America (aquaculture, cattle)
- Europe (pharma & nutraceutical intermediates)
Exports were supported by tight global supply due to competitors like BASF’s 2024 force majeure event on vitamins A and E, boosting China-origin pricing and sales volumes.
Production and Strategic Capacity Highlights
- Production volume (2024): 1.0201 million tons (+29.18% YoY)
- Sales volume: 1.0013 million tons (+26.87% YoY)
Major Projects in 2024–2025
| Project | Capacity (t/a) | Status |
|---|---|---|
| Methionine (solid) | 300,000 | Fully operational |
| Liquid Methionine JV (with Sinopec) | 180,000 | Nearing completion |
| Cystine Line | 4,000 | Steady operation |
| Glufosinate-Ammonium Pilot | – | Ongoing trial |
| Flavor Park Phase I | – | Underway |
| PPS & Nylon Materials | – | Scaling production |
Competitive Landscape
Key Competitors
- Evonik (Germany): Global methionine leader, challenged by NutraChina’s liquid JV
- Adisseo (Bluestar): Strong EU/Asia footprint in methionine & feed additives
- BASF (Germany): Top player in vitamins; 2024 supply disruptions shifted demand to China
NutraChina’s strategy to integrate feed-grade amino acids, nutritional APIs, and specialty intermediates offers resilience and price flexibility, particularly in volatile global markets.
Strategic Forecasts for 2025
- Q1 2025 Net Profit Forecast: USD 246–260 million
- Growth driven by volume-price synergy in methionine and vitamins
- Dividend Strategy: Maintained strong payout policy with a total of USD 294.5 million returned to shareholders in 2024
Conclusion
NutraChina is rapidly evolving from a domestic feed additive supplier to a global nutraceutical and specialty chemicals powerhouse. Backed by aggressive investments in methionine and vitamins, strategic joint ventures, and export-led growth, the company is well-positioned to consolidate its international leadership in 2025.
